AVXL · Anavex Life Sciences Corp. Common Stock
View on chartInsiders & Stakes
| MISSLING CHRISTOPHER U President and CEO | ▼ Sell | Tax Withholding | 1,510,165 Shares held | 9/11/2025 | View profile |
| Skarpelos Athanasios Director | ▼ Sell | Open Market | 1,306,458 Shares held | 5/25/2022 | View profile |
| Thomas Steffen Director | ▼ Sell | Tax Withholding | 43,651 Shares held | 6/5/2025 | View profile |
| Donhauser Peter D.O. Director | ▲ Buy | Open Market | 5,000 Shares held | 6/14/2024 | View profile |
Transaction History
| MISSLING CHRISTOPHER U | ▲ Buy | Option Exercise | 187,500 | $945K | 9/11/2025 |
| MISSLING CHRISTOPHER U | ▼ Sell | Tax Withholding | 145,048 | $1.4M | 9/11/2025 |
| Thomas Steffen | ▼ Sell | Tax Withholding | 11,349 | $88K | 6/5/2025 |
| Thomas Steffen | ▲ Buy | Option Exercise | 50,000 | $88K | 6/5/2025 |
| MISSLING CHRISTOPHER U | ▲ Buy | Option Exercise | 500,000 | $460K | 3/24/2025 |
| MISSLING CHRISTOPHER U | ▼ Sell | Tax Withholding | 282,497 | $2.7M | 3/24/2025 |
| Donhauser Peter D.O. | ▲ Buy | Open Market | 2,835 | $10K | 6/14/2024 |
| Thomas Steffen | ▲ Buy | Open Market | 5,000 | $23K | 5/15/2024 |
| MISSLING CHRISTOPHER U | ▲ Buy | Option Exercise | 73,380 | $97K | 3/28/2024 |
| MISSLING CHRISTOPHER U | ▼ Sell | Open Market | 73,380 | $375K | 3/28/2024 |
| MISSLING CHRISTOPHER U | ▲ Buy | Option Exercise | 232,000 | $371K | 6/29/2023 |
| MISSLING CHRISTOPHER U | ▲ Buy | Option Exercise | 268,000 | $429K | 6/28/2023 |
| MISSLING CHRISTOPHER U | ▼ Sell | Open Market | 268,000 | $2.1M | 6/28/2023 |
| Skarpelos Athanasios | ▲ Buy | Option Exercise | 50,000 | $46K | 5/25/2022 |
| Skarpelos Athanasios | ▼ Sell | Open Market | 50,000 | $453K | 5/25/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
AVXL Stockholders Elect All Director Nominees for 2026 Meeting
At the 2026 annual meeting, AVXL stockholders voted to elect all of the company's director nominees. The vote confirmed the current board composition and did not introduce any new directors. This routine corporate action is unlikely to change the company's strategic direction or operations in the short term.
AVXL Stockholders Elect All Director Nominees for 2026 Meeting. At the 2026 annual meeting, AVXL stockholders voted to elect all of the company's director nominees. The vote confirmed the current board composition and did not introduce any new directors. This routine corporate action is unlikely to change the company's strategic direction or operations in the short term.